Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
lidorestat (1 trial)
Diabetic Neuropathies (Phase 2)
Polyneuropathies (Phase 2)
Trials (1 total)
Trial APIs (1 total)